Polly Murphy

Polly Murphy

Director/Miembro de la Junta en ATEA PHARMACEUTICALS, INC. .

Fortuna: 1 M $ al 30/09/2026

61 años
Health Technology
Consumer Services

Perfil

Dr. Polly A. Murphy is a Chief Business Officer at Avadel Pharmaceuticals Plc, an Independent Director at Celcuity, Inc. and an Independent Director at Atea Pharmaceuticals, Inc. She is on the Board of Directors at Celcuity, Inc. and Atea Pharmaceuticals, Inc. Dr. Murphy was previously employed as a Chief Business Officer by UroGen Pharma Ltd., a Vice President-Commercial Development by Pfizer Inc., and a Senior VP-Business & Scientific Services by The Scripps Research Institute.
She received her MBA from Nova Southeastern University, Inc. and a doctorate degree from Iowa State University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
18/06/2026 121.745 ( 0,15 % ) 634 291 $ 30/09/2026
10/06/2026 5.000 ( 0,01 % ) 397 600 $ 30/09/2026

Cargos activos de Polly Murphy

EmpresasCargoInicio
ATEA PHARMACEUTICALS, INC. Director/Miembro de la Junta 01/08/2020
CELCUITY INC. Director/Miembro de la Junta 12/09/2022
AVADEL PHARMACEUTICALS PLC Corporate Officer/Principal 01/05/2024

Antiguos cargos conocidos de Polly Murphy.

EmpresasCargoFin
UROGEN PHARMA LTD. Corporate Officer/Principal 01/05/2024
PFIZER INC. Corporate Officer/Principal 01/08/2020
Corporate Officer/Principal 01/08/2008
Ver el detalle de la experiencia de Polly Murphy.

Formación de Polly Murphy.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

98

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology